Online citations, reference lists, and bibliographies.
← Back to Search

Understanding The Adsorption Of Salmon Calcitonin, Antimicrobial Peptide AP114 And Polymyxin B Onto Lipid Nanocapsules.

A. Umerska, N. Matougui, A. Groo, P. Saulnier
Published 2016 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The adsorption of therapeutic molecules, e.g., peptides, onto nanocarriers is influenced by the properties of the carrier, adsorbed molecule and continuous phase. Hence, through changes in the composition of the nanocarrier and the medium, it should be possible to tune the system to make it capable of efficiently adsorbing peptides. The adsorption of calcitonin, antimicrobial peptide AP114 and polymyxin B onto lipid nanocapsules was investigated. The adsorption data were fitted to a Langmuir isotherm. Dynamic light scattering and laser Doppler velocimetry were used to investigate the changes in the hydrodynamic diameter and zeta potential, respectively, of the nanocarrier. The peptide adsorption was primarily governed by electrostatic forces; however, even without the presence of an ionisable surfactant, a significant amount of each tested molecule was adsorbed due to the enormous surface area of the nanocarriers and to peptide-nanocarrier interactions. The addition of an ionisable lipophilic surfactant, lecithin, improved the adsorption yield, which reached values of up to 100%. The adsorption yield and the properties of the nanocarrier, particularly the zeta potential, depended on the carrier and peptide concentrations and their mixing ratio. The adsorption of all tested molecules obeyed the Langmuir model over a limited concentration range.
This paper references
10.1007/s11095-007-9459-1
Multifunctional Nanoparticulate Polyelectrolyte Complexes
Sean M. Hartig (2007)
10.1023/A:1016121319668
A Novel Phase Inversion-Based Process for the Preparation of Lipid Nanocarriers
B. Heurtault (2004)
10.1016/J.CEJ.2009.09.013
Insights into the modeling of adsorption isotherm systems
K. Y. Foo (2010)
10.1016/j.ijpharm.2012.07.011
Exploring the assembly process and properties of novel crosslinker-free hyaluronate-based polyelectrolyte complex nanocarriers.
A. Umerska (2012)
10.2217/fmb.12.120
A novel strategy to target bacterial virulence.
C. Baron (2013)
10.1155/2013/375830
Research Article Batch Sorption Experiments: Langmuir and Freundlich Isotherm Studies for the Adsorption of Textile Metal Ions onto Teff Straw (Eragrostis tef) Agricultural Waste
M. B. Desta (2013)
10.1016/J.PROGPOLYMSCI.2007.05.002
Spherical Polyelectrolyte Brushes
M. Ballauff (2007)
10.1016/j.ijpharm.2015.11.042
Synergistic interactions between doxycycline and terpenic components of essential oils encapsulated within lipid nanocapsules against gram negative bacteria.
C. Valcourt (2016)
10.1039/B300607G
Adsorption of proteins on spherical polyelectrolyte brushes in aqueous solution
A. Wittemann (2003)
10.1016/S0927-7757(03)00249-8
Viscoelastic properties of concentrated dispersions in water of soy lecithin
M. Manconi (2003)
10.2217/fmb.13.39
Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.
T. Velkov (2013)
10.1111/j.2042-7158.1974.tb09265.x
Adsorption of atropine and hyoscine on magnesium trisilicate
S. El-Masry (1974)
10.1007/BF02830562
Preparation, characterization, and in vivo evaluation of salmon calcitonin microspheres
B. Dani (2008)
10.1006/JCIS.1998.5513
Effect of chain density on inhibition of protein adsorption by poly(ethylene glycol) based coatings
M. Malmsten (1998)
10.1021/bm801513e
Polysaccharide-based polyelectrolyte complex nanoparticles from chitosan, heparin, and hyaluronan.
Soheil Boddohi (2009)
10.1002/JBM.820230306
Protein-resistant surfaces prepared by PEO-containing block copolymer surfactants.
J. Lee (1989)
10.1016/j.ijpharm.2015.07.008
Formulation and nebulization of fluticasone propionate-loaded lipid nanocarriers.
A. Umerska (2015)
10.1166/JBN.2014.1878
Self-assembled hyaluronate/protamine polyelectrolyte nanoplexes: synthesis, stability, biocompatibility and potential use as peptide carriers.
A. Umerska (2014)
10.1016/J.IJPHARM.2004.12.030
New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin.
M. Garcia-Fuentes (2005)
10.1128/AAC.01584-08
In Vivo Pharmacodynamic Characterization of a Novel Plectasin Antibiotic, NZ2114, in a Murine Infection Model
D. Andes (2009)
10.1016/J.ADDR.2007.04.007
Solid lipid nanoparticles as a drug delivery system for peptides and proteins.
A. Almeida (2007)
10.1186/1477-3155-11-26
Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle
S. Saptarshi (2013)
10.1016/S0021-9673(01)00585-4
Isolation and structural characterization of polymyxin B components.
J. Orwa (2001)
10.1016/j.ijpharm.2016.02.019
Lipid-based nanoformulations for peptide delivery.
N. Matougui (2016)
10.1021/JA034820Y
Factors that determine the protein resistance of oligoether self-assembled monolayers --internal hydrophilicity, terminal hydrophilicity, and lateral packing density.
S. Herrwerth (2003)
10.1016/J.COLSURFB.2005.03.009
Reorganization of lipid nanocapsules at air-water interface. I. Kinetics of surface film formation.
I. Minkov (2005)
10.1021/LA049460M
Formation and properties of positively charged colloids based on polyelectrolyte complexes of biopolymers.
C. Schatz (2004)
10.1016/j.ejpb.2015.04.006
Chondroitin-based nanoplexes as peptide delivery systems--Investigations into the self-assembly process, solid-state and extended release characteristics.
A. Umerska (2015)
10.1016/S0005-2736(02)00582-5
Interfacial tension of bilayer lipid membrane formed from phosphatidylethanolamine.
A. Petelska (2002)
10.1016/j.ijpharm.2009.04.026
Lipid nanocapsules: a new platform for nanomedicine.
N. Huynh (2009)
10.1016/j.ijpharm.2014.10.023
Intermolecular interactions between salmon calcitonin, hyaluronate, and chitosan and their impact on the process of formation and properties of peptide-loaded nanoparticles.
A. Umerska (2014)
10.1016/0021-9797(91)90043-8
Protein—surface interactions in the presence of polyethylene oxide: I. Simplified theory
S. Jeon (1991)
10.1021/MA990541C
Molecular design and in vitro studies of novel pH-sensitive hydrogels for the oral delivery of calcitonin
M. Torres-Lugo (1999)
10.1016/J.POLYMER.2013.03.027
Adsorption of proteins to functional polymeric nanoparticles
Nicole Welsch (2013)
10.1023/A:1016278902839
Adsorption of Salmon Calcitonin to PLGA Microspheres
S. Çalış (2004)
10.1002/ELPS.200410145
Electrokinetic properties of noncharged lipid nanocapsules: Influence of the dipolar distribution at the interface
A. Vonarbourg (2005)



This paper is referenced by
Assessment of the toxicity of lipid nanocapsules and polymer nanoparticles on a neuronal cell model as a first step towards their development for nose-to-brain drug delivery
Rifka Nurul Utami (2019)
10.1074/jbc.M117.791236
Growth-incompetent monomers of human calcitonin lead to a noncanonical direct relationship between peptide concentration and aggregation lag time
Kian Kamgar-Parsi (2017)
10.3389/fcimb.2019.00174
Characterization of the in vitro, ex vivo, and in vivo Efficacy of the Antimicrobial Peptide DPK-060 Used for Topical Treatment
J. Håkansson (2019)
10.1016/j.ejpb.2019.03.007
Intracellular availability of poorly soluble drugs from lipid nanocapsules
Marilena S Bohley (2019)
10.1111/cbdd.13031
Current state of a dual behaviour of antimicrobial peptides—Therapeutic agents and promising delivery vectors
U. Piotrowska (2017)
Antimicrobial and nanoparticle penetration and killing in infectious biofilms
René T. Rozenbaum (2019)
10.1002/IJCH.201600096
Structural Biology of Calcitonin: From Aqueous Therapeutic Properties to Amyloid Aggregation
Kian Kamgar-Parsi (2017)
10.36468/pharmaceutical-sciences.574
Technological Potential of Antimicrobial Peptides: a Systematic Review
E. Machado (2019)
10.1016/j.powtec.2020.02.028
Carbohydrate-based Trojan microparticles as carriers for pulmonary delivery of lipid nanocapsules using dry powder inhalation
Anita Umerska (2020)
10.1371/journal.pone.0179211
Surface active properties of lipid nanocapsules
C. R. Mouzouvi (2017)
10.1371/journal.pone.0189950
Antibacterial activity of antipsychotic agents, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity
H. Nehme (2018)
10.1080/07388551.2020.1796576
Antimicrobial peptides as therapeutic agents: opportunities and challenges
M. Mahlapuu (2020)
10.2147/IJN.S139625
Synergistic interactions between antimicrobial peptides derived from plectasin and lipid nanocapsules containing monolaurin as a cosurfactant against Staphylococcus aureus
A. Umerska (2017)
10.2217/nnm-2018-0337
A comparison of different strategies for antimicrobial peptides incorporation onto/into lipid nanocapsules.
N. Matougui (2019)
10.1016/j.jconrel.2020.05.002
Formulation technologies and advances for oral delivery of novel nitroimidazoles and antimicrobial peptides.
John Ndayishimiye (2020)
10.1039/c7cs00536a
Molecular engineering solutions for therapeutic peptide delivery.
H. Acar (2017)
10.1016/j.ijpharm.2017.04.082
Cubosomes post-loaded with antimicrobial peptides: characterization, bactericidal effect and proteolytic stability.
Lukas Boge (2017)
10.3389/fcimb.2016.00194
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
M. Mahlapuu (2016)
10.1016/j.ejpb.2016.09.001
Antibacterial action of lipid nanocapsules containing fatty acids or monoglycerides as co-surfactants.
A. Umerska (2016)
10.1016/j.jconrel.2018.11.018
Antimicrobial synergy of monolaurin lipid nanocapsules with adsorbed antimicrobial peptides against Staphylococcus aureus biofilms in vitro is absent in vivo
René T. Rozenbaum (2019)
Semantic Scholar Logo Some data provided by SemanticScholar